Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation

Molecular Medicine

Volumn 8, Issue 7, 2002, Pages 393-404

  Bodo, Maria ^a   Lilli, Cinzia ^a   Bellucci, Catia ^a   Carinci, Paolo ^a   Calvitti, Mario ^a   Pezzetti, Furio ^a   Stabellini, Giordano ^a   Bellocchio, Silvia ^a   Balducci, Chiara ^a   Carinci, Francesco ^a   Baroni, Tiziano ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BASIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; COLLAGEN; DNA; GLYCOSAMINOGLYCAN; GROWTH FACTOR RECEPTOR; OSTEOCALCIN; PROCOLLAGEN; PROTEOGLYCAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CANCER CLASSIFICATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DNA CONTENT; ENZYME REPRESSION; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; ISOTOPE LABELING; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PHENOTYPE; PRECURSOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS; RECEPTOR AFFINITY; RECEPTOR BINDING; RNA SPLICING; TUMOR DIFFERENTIATION;

EID: 0036430353     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402020     Document Type: Article

References (46)

1. Franchi A, Arganini L, Baroni G, et al. (1998) Expression of transforming growth factor beta isoforms in osteosarcoma variants: Association of TGF beta 1 with high-grade osteosarcomas. J. Pathol. 185: 284-289.
2. Girnita L, Girnita A, Wang M, et al. (2000) A link between basic fibroblast growth factor (bFGF) and Fewing's sarcoma cells. Oncogene 31: 4298-4301.
3. Yamaguchi F, Saya H, Bruner JM, Morrison RS. (1994) Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl. Acad. Sci. USA 91: 484-488.
4. Mason IJ. (1994) The ins and outs of fibroblast growth factors. Cell 78: 547-552.
5. Fedark NS, Termine JD, Young MF, Robey PG. (1990) Temporal regulation of hyaluronan and proteoglycan metabolism by human bone cellsin vitro. J. Biol. Chem. 265: 12200-12209.
6. Bodo M, Carinci P, Venti G, et al. (1997) Glycosaminoglycan metabolism and cytokine release in normal and otosclerotic human bone cells interleukin-1 treated. Connect. Tissue Res. 36: 231-240.
7. Mundy GR, Bratter FC. (1995) Factors regulating bone resorbing and bone forming cells. In: Bone Remodelling and its Disorders. San Antonio: Martin Dunitz, 39-65.
8. Harbour ME, Gregory JW, Jenkins HR, Evans BA. (2000) Proliferative response of different human osteoblast like cell proinflammatory cytokines. Pediatr. Res. 48: 163-168.
9. Szebenyi G, Fallon JF. (1999) Fibroblast growth factors as multifunctional signaling factors. Intern. Review of Citology Acad. Press 185: 45-105.
10. Bodo M, Baroni T, Carinci F, et al. (2000) Interleukin secretion, proteoglycan and procollagen alpha (1)(I) gene expression in Crouzon fibroblasts treated with basic fibroblast growth factor. Cytokine 12: 1280-1283.
11. Wilkie AOM. (1997) Craniosynostosis: Genes and mechanisms. Human Mol. Genet. 6: 1647-1656.
12. Bodo M, Baroni T, Carinci F, et al. (1999) A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan, and syndecan in osteoblasts from patients with Crouzon's syndrome. Eur. J. Cell Biol. 78: 323-330.
13. Carinci P, Becchetti E, Bodo M. (2000) Role of extracellular matrix and growth factors in skull morphogenesis and in pathogenesis of craniosynostosis. Int. J. Dev. Biol. 44: 715-723.
14. Clover J, Gowen M. (1994) Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the os-teoblastic phenotype? Bone 15: 585-591.
15. Bilbe G, Roberts E, Birch M, Evans DB. (1996) PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. Bone 19: 437-445.
16. MacPherson H, Noble BS, Ralston SH. (1999) Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells. Bone 24: 179-185.
17. Stewart M, Terry A, Hu M, et al. (1997) Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA(CBFA1): Evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. USA 94: 8646-8651.
18. Xiao ZS, Thomas R, Hinson TK, Quarles LD. (1998) Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214: 187-197.
19. Banerjee C, Javed A, Choi JY, et al. (2001) Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142: 4026-4039.
20. Ibbotson KJ, Harrod J, Gowen M, et al. (1986) Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formationin vitro. Proc. Natl. Acad. Sci. USA 83: 2228-2232.
21. Labarca C, Paigen KA. (1980) Simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102: 344-352.
22. Conrad GW, Hamilton C, Haynes E. (1977) Differences in glycosaminoglycans synthesized by fibroblast-like cells from chick cornea, heart, and skin. J. Biol. Chem. 252: 6861-6870.
23. Chomczynski P, Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
24. Maniatis T, Fritsch EF, Sambrook J. (1982) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
25. Fisher LW, Termine JD, Young MF. (1989) Deduced protein sequence of bone small proteoglycan 1 (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 264: 4571-4576.
26. Moscatelli D. (1987) High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol. 131: 123-130.
27. Hurley MM, Abreu C, Harrison JR, et al. (1993) Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268: 5588-5593.
28. Slater M, Patava J, Mason RS. (1994) Role of chondroitin sulfate glycosaminoglycans in mineralizing osteoblast-like cells: Effects of hormonal manipulation. J. Bone Miner. Res. 9: 161-169.
29. Hausser H, Schonherr E, Kresse H. (1993) Different galactosaminoglycan composition of small proteoglycans from osteosarcoma cells. Glycobiology 3: 557-562.
30. Kresse H, Hausser H, Schönherr E, Bittner K. (1994) Biosynthesis and interactions of small chondroitin/dermatan sulphate proteoglycans. Eur. J. Clin. Chem. Clin. Biochem. 32: 259-264.
31. Hocking AM, Shinomura T, McQuillan DJ. (1998) Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 17: 1-19.
32. Schönherr E, Witsch-Prehm P, Harrach B, et al. (1995) Interaction of Biglycan with Type I Collagen. J. Biol. Chem. 270: 2776-2783.
33. Vogel KG, Paulsson M, Heinegard D. (1984) Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 223: 587-597.
34. Merle B, Malaval L, Lawler J, et al. (1997) Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1. J. Cell Biochem. 67: 75-83.
35. Santra M, Mann DM, Mercer EW, et al. (1997) Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 100: 149-157.
36. Merle B, Durussel L, Delmas PD, Clezardin P. (1999) Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J. Cell Biochem. 75: 538-546.
37. Wegrowski Y, Gillery P, Kotlarz G, et al. (2000) Modulation of sulfated glycosaminoglycan and small proteoglycan synthesis by the extracellular matrix. Mol. Cell. Biochem. 205: 125-131.
38. Evangelisti R, Valeno V, Bosi G, et al. (1998) A contribution to the regulation of proteoglycan production: Modulation by TGFα, TGFβ and IL-1 of glycosaminoglycan biosynthesis on β-D-xiloside in chick embryo fibroblasts. Conn. Tissue Res. 37: 77-85.
39. Yayon A, Klagsbrun M, Esko JD, et al. (1991) Cell Surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.
40. Mignatti P, Morimoto T, Rifkin DB. (1998) Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc. Natl. Acad. Sci. USA 88: 11007-11011.
41. Mignatti P, Morimoto T, Rifkin DB. (1992) Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via s pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell. Physiol. 151: 81-93.
42. Bashkin P, Neufeld G, Gitay-Goren H, Vlodavsky I. (1992) Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C. J. Cell. Physiol. 151: 126-137.
43. Bodo M, Baroni T, Bellocchio S, et al. (2001) Bronchial epithelial cell matrix production in response to silica and basic fibroblast growth factor. Mol. Med. 7: 83-92
44. Benini S, Baldini N, Manara MC, et al. (1999) Redundancy of autocrine loops in human osteosarcoma cells. Int. J. Cancer 9: 581-588.
45. Slominski A, Wortsman J, Carlson A, et al. (1999) Molecular pathology of soft tissue and bone tumors. Arch. Pathol. Lab. Med. 123: 1246-1259.
46. Sulzbacher I, Traxler M, Mosberger I, et al. (2000) Platelet-derived growth factor-AA and alpha receptor expression suggest an autocrine and/or paracrine loop in osteosarcoma. Mod. Pathol. 13: 632-637.